shortagewatch

Home / Cancer and immune system / Dacomitinib

ATC L01EB07 · Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors · updated 2 Nov 2026

Dacomitinib shortage

As of 2 Nov 2026, Dacomitinib has a reported shortage in 1 of the 16 countries we track (United States), covering 3 products from 1 company.

Is there a Dacomitinib shortage?

Yes. As of 2 Nov 2026, Dacomitinib is reported short in 1 of the 16 countries we track: United States. No company has given a return date.

Countries1/16
Products3packs or presentations
Companies11 listed
Short since8 Jun 20265 months ago
Earliest returnnot givencompany estimate
Main reasonNot stated
United States3 products shortCanadaNo reported shortageGermanyNo reported shortageFranceNo reported shortageItalyNo reported shortageSpainNo reported shortageIrelandNo reported shortageAustriaNo reported shortageBelgiumNo reported shortageSwitzerlandNo reported shortageCzechiaNo reported shortageNorwayNo reported shortageSwedenNo reported shortageJapanNo reported shortageNew ZealandNo reported shortageAustraliaNo reported shortage

Timeline

United States
Vizimpro, Tablet, 15 mg (NDC 0069-0197-30)Vizimpro, Tablet, 15 mg (NDC 0069-0197-30)Vizimpro, Tablet, 30 mg (NDC 0069-1198-30)Vizimpro, Tablet, 30 mg (NDC 0069-1198-30)Vizimpro, Tablet, 45 mg (NDC 0069-2299-30)Vizimpro, Tablet, 45 mg (NDC 0069-2299-30)today

Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.

Which companies are short

products short, all countries
Pfizer3 PFE

Listed: Pfizer PFE · NYSE

Compared with similar medicines

ATC group L01EB · Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors
Erlotinib5/16Gefitinib2/16Afatinib1/16Dacomitinib1/16

Affected products

CountryProductCompanySinceExpected backReason
USVizimpro, Tablet, 15 mg (NDC 0069-0197-30) discontinuationPfizer Inc.8 Jun 2026not givenNot stated
USVizimpro, Tablet, 30 mg (NDC 0069-1198-30) discontinuationPfizer Inc.8 Jun 2026not givenNot stated
USVizimpro, Tablet, 45 mg (NDC 0069-2299-30) discontinuationPfizer Inc.8 Jun 2026not givenNot stated

"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.

Questions

Is there a Dacomitinib shortage?

Yes. As of 2 Nov 2026, Dacomitinib is reported short in 1 of the 16 countries we track: United States. No company has given a return date.

When will Dacomitinib be back in stock?

No return date has been given; United States: no date given. These are company estimates reported to each authority.

Why is Dacomitinib in short supply?

The most common reason reported is: not stated. Reasons by product are listed in the table below.

Which companies have Dacomitinib shortages?

Pfizer.